Navigation Links
AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso
Date:7/24/2014

REDWOOD CITY, Calif., July 24, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today confirmed the PDUFA date for Zalviso remains July 27, 2014. 

The company recently learned that a rumor circulated online stating the Food and Drug Administration (FDA) had approved Zalviso.  As of July 24, 2014 there has been no notification to the company from the FDA regarding the status of the Zalviso New Drug Application (NDA). 

About AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.  AcelRx's lead product candidate, ZALVISO, is designed to improve the management of moderate-to-severe acute pain in adult patients in the hospital setting by utilizing a high therapeutic index opioid, through a non-invasive delivery route via a pre-programmed, patient-controlled analgesia device. AcelRx has announced positive results from each of the three completed Phase 3 clinical trials for ZALVISO, and has submitted an NDA to the FDA seeking approval for ZALVISO in the treatment of moderate-to-severe acute pain in adult patients in the hospital setting.  AcelRx plans to initiate a Phase 3 clinical trial for ARX-04, a product candidate for the treatment of moderate-to-severe acute pain in a medically supervised setting, during the second half of 2014. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development.  For additional information about AcelRx's clinical programs, please visi
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
2. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
3. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
7. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
8. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
9. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , N.J. and NEW BRUNSWICK, N.J., Sept. 30, 2014 /PRNewswire-USNewswire/ ... that allows Kessler Foundation and New Jersey Health ... research, education and patient care programs has been ... chief executive officer of Kessler Foundation and ... Health Foundation. "The experience of New ...
(Date:9/30/2014)... 2014  Georgia-Pacific Professional is a leading provider ... a wide range of away from home applications. ... in healthcare, including hospitals, long-term care facilities, surgical ... its healthcare products and solutions to the dental ... of infection control in the dental office," said ...
(Date:9/30/2014)... -- In a recent study it was ... the Eldor spinal needle 25G, 103 mm appeared significantly ... spinal needles of the same gauge and length of ... an excellent type of regional anesthesia for many operations ... It is estimated that 100 million patients worldwide ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3
... SAN DIEGO, Sept. 26, 2011 Elevation Pharmaceuticals, Inc., ... aerosol therapies for patients with respiratory diseases, today announced ... and Chief Business Officer and Pravin Soni, PhD, as ... created positions. The company also announced that it drew ...
... 26, 2011 Clermont Pharmaceuticals, Inc., a ... positive results from a phase III trial ... latanoprost was compared to Xalatan® (latanoprost ophthalmic ... glaucoma.  Non-preserved latanoprost achieved the primary efficacy ...
Cached Medicine Technology:Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 2Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 3Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma 2
(Date:9/30/2014)... September 30, 2014 Coast Dental ... opening of its newest practice, located at 1010 Shaw ... x-rays, general dentistry services , and specialty dental ... addition to providing affordable and convenient dental care, our ... dental appointments . Call Coast Dental at 559-777-6113 to ...
(Date:9/30/2014)... September 30, 2014 In its latest blog ... and believes that having family close by during a stay ... not the process is successful, is focusing on 5 reasons ... lasting recovery. , “Achieving sobriety is not a one-time event, ... Drug Rehabilitation’s CEO Per Wickstrom . “It’s an ongoing ...
(Date:9/30/2014)... 2014 More than 23 per cent of Canadians report ... stress increases the risk of poor mental and physical health, ... but for others especially those most likely to sweat ... , Thankfully, new research from Concordia University has found a ... huge help for healthcare professionals working to stop stress before ...
(Date:9/30/2014)... Rochelle, NY, September 30, 2014Levothyroxine (L-T4), long the ... in most patients, but some individuals do not ... about thyroid physiology may help to explain these ... Thyroid Association on thyroid hormone replacement reviewed the ... treatments to determine whether a change to the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 OZ Naturals ... selling beauty brand on Amazon.com. , “The majority of ... respective beauty categories on Amazon.com,” said Craig Romero, CEO of ... UK on Amazon.co.uk and Canada on Amazon.ca , Romero went ... just launched earlier last month, are already taking over top ...
Breaking Medicine News(10 mins):Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 2Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 3Health News:How to predict who will suffer the most from stress 2Health News:New hypothyroidism treatment guidelines from American Thyroid Association 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 3
... More than nine million people, or 34 percent of ... drug benefit through Medicare Advantage plans with prescription drug ... Using just released data from the Center for ... database, Avalere researchers analyzed 2009 Medicare Part D open ...
... ST. LOUIS, Feb. 24 The deepening economic ... some would say failing -- health care,system at ... number of,uninsured and underinsured is rising. Also, faced ... those with insurance are not compliant in,taking critical ...
... and states reconsider funding for abstinence-only programs, the largest ... classes reveals that abstinence programs are plagued with factual ... and actively discourage the use of condoms to protect ... Texas Freedom Network Education Fund - Just Say ...
... women, but different genes might raise risk in black women ... a genetic marker that may indicate if a woman has ... says. , Shorter, white women who test positive for the ... to develop the muscular tumors in their uterus, according to ...
... study published in the February 2009 issue of the ... a highly reliable depression screening tool known as the ... and Europe can be effectively administered in resource poor ... needs have been underserved. The work also confirms that ...
... U.S. editors and producers traveled to Uganda last year ... fascinating countries. A highlight of the International Reporting Project ... and HIV/AIDS with Ugandan President Yoweri Museveni. At the ... three of the Gatekeepers will discuss the U.S. media,s ...
Cached Medicine News:Health News:1 in 3 Medicare Part D Enrollees Select Medicare Advantage Drug Plans for 2009 2Health News:Health and Wellness Programs in a Tight Economy: Why They Are Critical and How to Make Them Effective 2Health News:New Texas Study Reveals Serious Flaws in Abstinence Programs 2Health News:Inexpensive depression screening tool works in resource poor countries 2Health News:U.S. Media Report From Uganda: Wilson Center Panel Discusses Health, Environment, and Security in Africa 2
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... wide variety of applications. • Whole pipette is ... freely rotated against the handle to work in ... angle towards the microtiter plate. • The special ... common pipette tips, and provides a firm, parallel ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
Medicine Products: